Wednesday, May 18, 2022

Latest:

Healthy Habits: Dr. Felicia Skelton-Dudley starts her day with quiet reflection and practices yoga
Dr. Susan Rosenberg elected to AAAS Board of Directors
Spring cleaning safety tips
Social burnout post-pandemic
Alone at the hands of healthcare: hospital visitor policies during the COVID-19 pandemic

Baylor College of Medicine Blog Network

Blog Network
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

CD19

From The Labs

Trading a spear for a trident is promising in the fight against leukemia

April 14, 2020April 14, 2020ALL, CART cells, CD19, CD20, CD22, pediatric leukemia, Research

Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer. While most children respond well to chemotherapy, some experience resistant or relapsed disease. Building on

From the Labs: A closer look at tertiary lymphoid structures. Image courtesy of M. Zelazowski/ P. Castro/Baylor’s Human Tissue Acquisition & Pathology (HTAP) Core.